XML 40 R28.htm IDEA: XBRL DOCUMENT
v3.19.1

Revenue (Tables) | 6 Months Ended
--- | ---
Mar. 30, 2019
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:
|  | Three Months Ended March 30, 2019 |  | Three Months Ended March 31, 2018
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 76.6 |  | $ | 38.9 |  | $ | 115.5 |  |  | $ | 78.5 |  | $ | 39.2 |  | $ | 117.7 |
| Molecular Diagnostics | 136.8 |  | 31.0 |  | 167.8 |  |  | 123.7 |  | 27.0 |  | 150.7 |
| Blood Screening | 13.4 |  | — |  | 13.4 |  |  | 11.3 |  | — |  | 11.3 |
Total | $ | 226.8 |  | $ | 69.9 |  | $ | 296.7 |  |  | $ | 213.5 |  | $ | 66.2 |  | $ | 279.7 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 206.2 |  | $ | 59.7 |  | $ | 265.9 |  |  | $ | 191.7 |  | $ | 58.7 |  | $ | 250.4 |
| Interventional Breast Solutions | 46.8 |  | 8.8 |  | 55.6 |  |  | 40.8 |  | 8.9 |  | 49.7 |
Total | $ | 253.0 |  | $ | 68.5 |  | $ | 321.5 |  |  | $ | 232.5 |  | $ | 67.6 |  | $ | 300.1 |
Medical Aesthetics | $ | 37.6 |  | $ | 36.2 |  | $ | 73.8 |  |  | $ | 44.4 |  | $ | 41.1 |  | $ | 85.5 |
GYN Surgical | $ | 84.1 |  | $ | 18.1 |  | $ | 102.2 |  |  | $ | 82.4 |  | $ | 17.0 |  | $ | 99.4 |
Skeletal Health | $ | 14.0 |  | $ | 10.2 |  | $ | 24.2 |  |  | $ | 15.7 |  | $ | 8.9 |  | $ | 24.6 |
|  | $ | 615.5 |  | $ | 202.9 |  | $ | 818.4 |  |  | $ | 588.5 |  | $ | 200.8 |  | $ | 789.3 |
|  | Six Months Ended March 30, 2019 |  | Six Months Ended March 31, 2018
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 155.8 |  | $ | 77.8 |  | $ | 233.6 |  |  | $ | 163.2 |  | $ | 77.9 |  | $ | 241.1 |
| Molecular Diagnostics | 270.9 |  | 61.2 |  | 332.1 |  |  | 247.6 |  | 51.7 |  | 299.3 |
| Blood Screening | 27.6 |  | — |  | 27.6 |  |  | 23.9 |  | — |  | 23.9 |
Total | $ | 454.3 |  | $ | 139.0 |  | $ | 593.3 |  |  | $ | 434.7 |  | $ | 129.6 |  | $ | 564.3 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 412.7 |  | $ | 122.9 |  | $ | 535.6 |  |  | $ | 371.5 |  | $ | 114.8 |  | $ | 486.3 |
| Interventional Breast Solutions | 92.9 |  | 17.7 |  | 110.6 |  |  | 85.4 |  | 16.4 |  | 101.8 |
Total | $ | 505.6 |  | $ | 140.6 |  | $ | 646.2 |  |  | $ | 456.9 |  | $ | 131.2 |  | $ | 588.1 |
Medical Aesthetics | $ | 74.9 |  | $ | 78.7 |  | $ | 153.6 |  |  | $ | 91.0 |  | $ | 85.8 |  | $ | 176.8 |
GYN Surgical | $ | 175.2 |  | $ | 35.4 |  | $ | 210.6 |  |  | $ | 173.9 |  | $ | 33.0 |  | $ | 206.9 |
Skeletal Health | $ | 27.2 |  | $ | 18.2 |  | $ | 45.4 |  |  | $ | 29.3 |  | $ | 15.0 |  | $ | 44.3 |
|  | $ | 1,237.2 |  | $ | 411.9 |  | $ | 1,649.1 |  |  | $ | 1,185.8 |  | $ | 394.6 |  | $ | 1,580.4 |
|  | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended
Geographic Regions (in millions) |  | March 30, 2019 | March 31, 2018 | March 30, 2019 | March 31, 2018
United States |  | $ | 615.5 |  | $ | 588.5 |  | $ | 1,237.2 |  | $ | 1,185.8 |
Europe |  | 102.1 |  | 99.3 |  | 203.2 |  | 190.6 |
Asia-Pacific |  | 64.3 |  | 62.0 |  | 134.0 |  | 130.4 |
Rest of World |  | 36.5 |  | 39.5 |  | 74.7 |  | 73.6 |
|  | $ | 818.4 |  | $ | 789.3 |  | $ | 1,649.1 |  | $ | 1,580.4 |
The following table provides revenue recognized by source:
|  | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended
Revenue by type (in millions) |  | March 30, 2019 | March 31, 2018 | March 30, 2019 | March 31, 2018
Capital equipment, components and software |  | $ | 239.4 |  | $ | 239.6 |  | $ | 487.8 |  | $ | 446.0 |
Consumables |  | 428.4 |  | 405.4 |  | 863.1 |  | 849.7 |
Service |  | 141.1 |  | 138.0 |  | 283.0 |  | 273.4 |
Other |  | 9.5 |  | 6.3 |  | 15.2 |  | 11.3 |
|  | $ | 818.4 |  | $ | 789.3 |  | $ | 1,649.1 |  | $ | 1,580.4 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration